Albany, New York (PRWEB) August 27, 2013
Marine Biotech Market report is designed for clients needing a quality in-depth understanding of the dynamics and structure of the Marine Biotech Market report. These reports provide a much more granular and detailed data set than our competitors. All data have been researched, brand upwards, by an experienced ''on-the-ground'' industry analyst who conducts face-to-face interviews with key producers, leading companies in allied industries, distributors and retailers.
Complete Report With TOC @ http://www.researchmoz.us/global-marine-biotech-market-2012-2016-report.html.
Global Marine Biotech market to grow at a CAGR of 3.82 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in the demand for natural products. The Global Marine Biotech market has also been witnessing increasing investments from venture capitalists. However, high R&D costs could pose a challenge to the growth of this market.
TechNavio's report, the Global Marine Biotech Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Marine Biotech market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this space include Aker BioMarine AS, Aqua Bio Technology ASA, Cyanotech Corp., and Royal DSM NV.
The other vendors mentioned in this report are ABL Biotechnologies Ltd., Aquapharm Biodiscovery Ltd., Biotech Marine, CP Kelco, Elan Corp. plc, FMC Biopolymer AS, Frutarom USA Inc., GeoMarine Biotechnologies, GlycoMar
Copyright©2012 Vocus, Inc.
All rights reserved